- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-associated bone disease
Authors
Keywords
Bone, Cancer, IOF, Skeletal-related events
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 24, Issue 12, Pages 2929-2953
Publisher
Springer Nature
Online
2013-10-21
DOI
10.1007/s00198-013-2530-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER (+) breast cancer
- (2013) Nicola Napoli et al. BONE
- Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
- (2013) R. Rizzoli et al. CURRENT MEDICAL RESEARCH AND OPINION
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis
- (2013) Nelson Watts et al. Endocrine Practice
- International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease
- (2013) Evangelos Terpos et al. JOURNAL OF CLINICAL ONCOLOGY
- Calcium supplements and cardiovascular risk in the Women’s Health Initiative
- (2013) M. J. Bolland et al. OSTEOPOROSIS INTERNATIONAL
- Prevention of falls in the elderly—a review
- (2013) M. K. Karlsson et al. OSTEOPOROSIS INTERNATIONAL
- Bone Health in Adult Cancer Survivorship
- (2012) Maryam B. Lustberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper
- (2012) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy
- (2011) B. Bouvard et al. ANNALS OF ONCOLOGY
- Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
- (2011) P. Hadji et al. ANNALS OF ONCOLOGY
- Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial
- (2011) Antonella L. Rastelli et al. BREAST CANCER RESEARCH AND TREATMENT
- Guidelines for the diagnosis and management of multiple myeloma 2011
- (2011) Jennifer M. Bird et al. BRITISH JOURNAL OF HAEMATOLOGY
- Aging and osteoporosis in breast and prostate cancer
- (2011) Ari VanderWalde et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Osteoporosis Canada 2010 Guidelines for the Assessment of Fracture Risk
- (2011) Brian Lentle et al. CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
- UK Guidance Document: Treatment of Metastatic Breast Cancer
- (2011) R.E. Coleman et al. CLINICAL ONCOLOGY
- Consensus on the utility of bone markers in the malignant bone disease setting
- (2011) Robert Coleman et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
- (2011) C.L. Shapiro et al. EUROPEAN JOURNAL OF CANCER
- Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
- (2011) Hui-Lin Yang et al. EUROPEAN RADIOLOGY
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2011) Nicolas Mottet et al. EUROPEAN UROLOGY
- American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
- (2011) Catherine H. Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- The Fracture Risk Assessment Tool (FRAX®): Applications in Clinical Practice
- (2011) Nelson B. Watts JOURNAL OF WOMENS HEALTH
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of osteoporosis among cancer patients in Germany
- (2011) M. Reuss-Borst et al. OSTEOPOROSIS INTERNATIONAL
- Interpretation and use of FRAX in clinical practice
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonates for post-menopausal osteoporosis: are they all the same?
- (2011) R. Rizzoli QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Gynaecological masses: imaging and pathology
- (2011) J.A. Spencer CANCER IMAGING
- A Review of Osteoporosis Diagnosis and Treatment Options in New and Recently Updated Guidelines on Case Finding Around the World
- (2011) William D. Leslie et al. Current Osteoporosis Reports
- American Society of Clinical Oncology Clinical Practice Guideline Update: Recommendations on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
- (2011) Catherine H. Van Poznak et al. Journal of Oncology Practice
- Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer
- (2010) L. B. Michaud AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Computed Microtomography of Bone Specimens for Rapid Analysis of Bone Changes Associated With Malignancy
- (2010) Daniel Chappard et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer
- (2010) Pamela Taxel et al. BJU INTERNATIONAL
- Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01)
- (2010) Jeong Eun Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor
- (2010) Peyman Hadji Breast Care
- High Prevalence of Low Vitamin D and Musculoskeletal Complaints in Women with Breast Cancer
- (2010) Nicola Napoli et al. Breast Journal
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- (2010) A. Papaioannou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Metastasis and bone loss: Advancing treatment and prevention
- (2010) Robert E. Coleman et al. CANCER TREATMENT REVIEWS
- Response to questions regarding conclusions reached in “Age dependence of femoral strength in white women and men”
- (2010) Tony M Keaveny JOURNAL OF BONE AND MINERAL RESEARCH
- Impact of Androgen-Deprivation Therapy on Physical Function and Quality of Life in Men With Nonmetastatic Prostate Cancer
- (2010) Shabbir M.H. Alibhai et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Application of a Fracture Risk Algorithm to Men Treated With Androgen Deprivation Therapy for Prostate Cancer
- (2010) Philip J. Saylor et al. JOURNAL OF UROLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Management of osteoporosis in men on androgen deprivation therapy
- (2010) Robert A. Adler MATURITAS
- American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
- (2010) Kathryn H. Schmitz et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Bone mineral density and prevalent osteoarthritis of the hip in older men for the Osteoporotic Fractures in Men (MrOS) Study Group
- (2010) R. K. Chaganti et al. OSTEOPOROSIS INTERNATIONAL
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Development and use of FRAX® in osteoporosis
- (2010) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Assessment of Individual Fracture Risk: FRAX and Beyond
- (2010) Joop P. W. van den Bergh et al. Current Osteoporosis Reports
- The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
- (2009) E. Terpos et al. ANNALS OF ONCOLOGY
- Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer
- (2009) Mirieme Ghazi et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Pathological fracture prediction in patients with metastatic lesions can be improved with quantitative computed tomography based computer models
- (2009) Esther Tanck et al. BONE
- Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study
- (2009) Georgiana K. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast Cancer
- (2009) Philip Shie et al. CLINICAL NUCLEAR MEDICINE
- Insufficiency Fractures After Pelvic Radiotherapy in Patients With Prostate Cancer
- (2009) Şefik İğdem et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical Value of Monitoring BMD in Patients Treated With Bisphosphonates for Osteoporosis
- (2009) Nelson B Watts et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
- (2009) Dawn L. Hershman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation
- (2009) Ali G. Saad et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis
- (2009) Colleen M Costelloe et al. LANCET ONCOLOGY
- Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
- (2009) David P Dearnaley et al. LANCET ONCOLOGY
- Risks of osteoporosis associated with breast cancer treatment: The need to access to preventive treatment
- (2009) Serge Rozenberg et al. MATURITAS
- Prevention of osteoporosis after breast cancer
- (2009) David M. Reid MATURITAS
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantification of Dendritic Cells and Osteoclasts in the Bone Marrow of Patients with Monoclonal Gammopathy
- (2009) Nicolas Josselin et al. PATHOLOGY & ONCOLOGY RESEARCH
- Male gonadal toxicity
- (2009) Marvin L. Meistrich PEDIATRIC BLOOD & CANCER
- Peripheral or Axial Bone Density Measurements to Identify Osteoporosis in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy?
- (2009) Vivek K. Wadhwa et al. UROLOGY
- Skeletal sequelae of cancer and cancer treatment
- (2009) Charles J. Stava et al. Journal of Cancer Survivorship
- Practical guidance for the management of aromatase inhibitor-associated bone loss
- (2008) P. Hadji et al. ANNALS OF ONCOLOGY
- Preface
- (2008) Robert G. Bristow CANCER AND METASTASIS REVIEWS
- Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
- (2008) David M. Reid et al. CANCER TREATMENT REVIEWS
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Vertebral Fracture Assessment (VFA) With a Densitometer Predicts Future Fractures in Elderly Women Unselected for Osteoporosis
- (2008) Eugene V McCloskey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer
- (2008) Fred Saad et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
- (2008) LANCET ONCOLOGY
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
- Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole
- (2008) A. Brufsky et al. ONCOLOGIST
- Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors
- (2008) Kelli Gibson et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
- (2006) Carolyn M. Klotzbuecher et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started